{"conversation_id": "1277559777569067008", "text": "We announced the price today for our investigational antiviral for the treatment of COVID-19. We believe our unique approach will provide broad and equitable access. Read more from our Chairman &amp; CEO: https://t.co/rrEbrDxrLk. https://t.co/9ElSExqSU3", "author_id": "309728693", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}], "attachments": {"media_keys": ["3_1277558901240545281"]}, "entities": {"urls": [{"start": 205, "end": 228, "url": "https://t.co/rrEbrDxrLk", "expanded_url": "https://bit.ly/3i6GL5f", "display_url": "bit.ly/3i6GL5f"}, {"start": 230, "end": 253, "url": "https://t.co/9ElSExqSU3", "expanded_url": "https://twitter.com/GileadSciences/status/1277559777569067008/photo/1", "display_url": "pic.twitter.com/9ElSExqSU3"}]}, "possibly_sensitive": false, "reply_settings": "everyone", "lang": "en", "source": "Twitter Web App", "public_metrics": {"retweet_count": 296, "reply_count": 3034, "like_count": 537, "quote_count": 1904}, "id": "1277559777569067008", "created_at": "2020-06-29T11:09:21.000Z"}